Abstract. Molecular biology of esophageal adenocarcinoma (EAC) is not fully elucidated.
INTRODUCTION
E sophageal adenocarcinoma (EAC) generally has a very poor prognosis [1] . The incidence of EAC has increased substantially during the last four decades in Western countries and probably will continue to rise [2] . Carcinogenesis of EAC is а complex, multistep and multifactorial process in which a lot of genetic abnormalities are discovered. Nevertheless, molecular alterations in EAC are not completely clarifi ed. Inactivation of tumor suppressors responsible for the maintenance of normal cell cycle often occurs in the carcinogenesis of EAC [3] . One of the key molecular players in the cell cycle control is p16. Tumor suppressor p16 is a cyclin-dependent kinases (cdk) inhibitor that blocks the activity of cyclin-D-cdk4/6 complex, and thus inhibits the phosphorylation of pRb and G1/S phase cell cycle transition [4] . Loss of p16 could lead to unrestrained cell proliferation and genomic instability, because insensitivity to antigrowth signals is one of the hallmarks of cancer [5] . p16 has been found to lie within the 9p21 region and loss of p16 is frequently observed in many malignant disorders, although overexpression of p16 is demonstrated in some tumors [6, 7, 8, 9] . p16 loss occurs predominantly by gene deletion, promoter methylation, and point mutation [10, 11, 12, 13] . Allelic losses of 9p21 are detected in EAC carcinogenesis and confl icting data exist whether these changes develop early or late in the malignant progression from Barrett's esophagus to esophageal adenocarcinoma [14, 15] . Study of the expression of p16 could help in the comprehension of EAC pathogenesis. This marker could also become an appropriate molecule in the targeted therapy of EAC. Promising results are obtained from p16 gene therapy studies in different cancers, including esophageal cancer [16, 17, 18, 19] .
Therefore, the aim of this study was to evaluate the expression of p16 at protein and gene level. We retrospectively assessed p16 protein expression by immunohistochemistry (IHC) and 9p21 (p16 gene) genomic loss by fl uorescence in situ hybridization (FISH) in tissue samples of patients with EAC. Our results showed that absent expression of p16 both at protein and gene level is common in EAC. Signifi cant correlation was found also between the p16 protein expression and p16 allelic loss.
MATERIAL AND METHODS

Patients and tissue sampling
Formalin-fi xed, paraffi n embedded (FFPE) archival blocks from 13 patients with EAC obtained by endoscopic biopsies and surgical resections were studied. Tissue samples were evaluated by two experienced histopathologists. Medical records of all patients were thoroughly reviewed. None of the patients has been treated with neoadjuvant chemotherapy or chemoradiotherapy.
Immunohistochemistry
Immunohistochemical analysis for the protein expression of p16 was completed on all cases. 5 μm thick FFPE tissue sections were placed on silanized slides, deparaffi ned and rehydrated in decreasing concentrations of ethanol. Antigen retrieval was carried out by immersing the slides in 10 mM modifi ed citrate buffer with pH 6.1 (DAKOCytomation, Denmark) and heated in a microwave oven (700 W) 4 times for 5 min. Endogenous peroxidase activity was blocked by incubation of the slides in 3% hydrogen peroxide (H2O2) for 5 min. Slides were incubated for one hour at room temperature with monoclonal mouse anti-human antibody against p16 (Clone 175-405, IgG1; Pharmingen, Hamburg, Germany) at a dilution of 1:50. LSAB+ visualization kit was used (DAKOCytomation, Denmark). Specimens were incubated with a secondary biotinylated anti-mouse antibody (DAKOCytomation, Denmark) for 15 min and then incubated with peroxidaselabelled streptavidin. The reaction was developed by immersing slides in 3,3'-diaminobenzidine (DAB) chromogen solution that results in brown staining in the positive cells. Specimens were counterstained with hematoxylin, dehydrated in ascending concentrations of ethanol and mounted with non-aqueous mounting medium. Negative controls were performed by omission of the primary antibody. Positive staining of normal, non-neoplastic epithelial cells, fi broblasts and lymphocytes within analyzed specimens served as an internal positive control. More than 500 cancer cells were counted in fi ve representative high-power magnifi cation fi elds (400x) for each specimen. Scoring was based on the percentage of the stained epithelial cancer cells and nuclear staining was considered positive. The analyzed specimens were scored into four groups as follows: 0 (negative expression, 0-25%); 1+ (weak expression, 26-50%); 2+ (moderate expression, 51-75%); and 3+ (strong expression, 76-100%), regardless of staining intensity.
FISH
For detection of 9p21 deletions, FISH was performed on the same 13 EAC specimens. Specimens were dewaxed by three 5-min immersions in xylene, dehydrated in two 5-min 100% ethanol washes, followed by drying on a 40°C slide warmer for 5 min. Pretreatment kit (Vysis, Downers Grove, IL, USA) UK) was used and the slides were consecutively immersed in 0.2N HCL for 20 min, in purifi ed water, and in Pretreatment Solution at 80°C for 15 minutes, followed by immersion of the slides twice in purifi ed water for 1 minute, and in Wash Buffer for 5 minutes. Protease treating of the slides was done by immersing the slides in protease solution for 30 min at 37°C, followed by immersion of the slides in Wash Buffer. The slides were dehydrated with increasing concentration of ethanol at room temperature. Locus specifi c identifi er (LSI) p16 SpectrumOrange/centromeric enumeration probe (CEP) 9 Green Dual Color Probe (Vysis, Downers Grove, IL, USA) was used in the hybridization. The DNA probe (1 μl DNA probe + 7 μl hybridization buffer + 2 μl purifi ed water) and the target DNA were codenatured in slide warmer at 75°C for 5 min. Then the slides were coverslipped and incubated in a humidifi ed chamber at 37°C for 24 hours. After washing the slides with Wash Buffer -2XSSC/0.1% (Vysis, Downers Grove, IL, USA) and nonionic detergent 0.3%NP40 (Vysis, Downers Grove, IL, USA), the slides were washed twice with purifi ed water and dried at room temperature. Counterstaining was performed with 10 μl 4',6-Diamidino-2-phenylindole (DAPI) (Vysis, Downers Grove, IL, USA) and slides were coverslipped. An Olympus BX60 epifl uorescence microscope was utilized for scoring the signals. The loss of p16 FISH signals was analyzed in minimum 50 nonsquamous cells in every slide and damaged or overlapping nuclei were excluded from the analysis. Loss of LSI p16 probe signals compared to the corresponding CEP 9 or gain (> 2 FISH signals) of CEP was determined as an abnormal FISH result. We used squamous esophageal tissues as controls to establish the background hybridization variation. The cut-off levels for p16 deletions were defi ned as the mean percentage of cells + 3 SD of the signal losses displayed in the evaluated control samples. The mean + 3 SD percentage of nuclei with losses of one LSI p16 (9p21) signal (hemizygous deletion), two LSI p16 (9p21) signals (homozygous deletion) and one and two LSI p16 (9p21) signals (combination of hemizygous and homozygous deletion) was 8%, 5% and 6%, respectively.
Statistical Analysis
Fisher's Exact Test and Cramer's V coeffi cient (V) were used for statistical analysis. SPSS (version 13.0; SPSS, Chicago, IL) statistical software was used for statistical analysis. Statistical signifi cance was defi ned as p < 0.05.
RESULTS
Of the patients, 10 were male and 3 were female with an age range of 45-80 (mean of 62 years). Of the tumors, 2 were categorized as Stage 2B, 6 as Stage 3, and 5 as Stage 4 according to the TNM staging system and classifi cation of the American Joint Committee on Cancer (AJCC). Tumor differentiation grade was determined using the criteria of the World Health Organization, and 1 tumor was graded as well differentiated (G1), 6 as moderately differentiated (G2), and 6 as poorly differentiated (G3). Loss of p16 protein expression was observed in 10 of 13 (77%) immunohistochemically analyzed EAC specimens. Weak p16 immunostaining was found in 2 of 13 (15%) EAC specimens and strong p16 immunostaining was found in 1 of 13 (8%) EAC specimens (Fig. 1a) . Loss of p16 gene was detected in 9 of 13 (69%) EAC specimens studied by FISH. Hemizygous deletion occurred with highest frequency and was found in 7 of 13 (54%) EAC specimens (Fig. 1b) , whereas homozygous deletion of p16 and combination of hemizygous and homozygous p16 deletion were presented in 2 of 13 (15%) EAC specimens. Detailed data for the protein and gene expression patterns of p16 are shown in Table 1 .
Using a Fisher's Exact Test, a signifi cant correlation was found between the loss of p16 protein expression and the p16 allelic loss (p = 0.014) in the analyzed specimens. The statistical analysis also shows that Cramer's V Coeffi cient (V) is statistically significant (Approx.Sig = 0,003) with V = 0,822.
DISCUSSION
EAC occurs commonly with increasing age, which coincides with our fi ndings. Higher number of men with EAC in our study is anticipated, because for unknown reasons male predominance is particularly strong in this cancer [20, 21] . More severe gastroesophageal refl ux found in men is considered as putative contributing factor for higher incidence of EAC in male individuals [22] .
FISH and IHC are proper and complimentary techniques to estimate the molecular alterations at protein and gene level in human cancers. ICH detects protein (antigen) expression within tissues by application of antibodies and is very helpful in the diagnosis of different cancers [23, 24] . Advantages of IHC are high sensitivity and comparatively low cost. FISH technique is also an important tool in cancer research and is characterized by the utilization of fl uorescent DNA probes to localize and visualize gene or chromosome abnormalities [25] . FISH is possible due to the stability of the DNA double helix and the ability of the DNA helix to renature. FISH is more accurate, reproducible and notably could be used for examination of resting cells in interphase. FISH allows analysis of chromosomal disturbances even in samples in bad condition. Drawbacks of FISH include higher price, inability to value the pathomorphological alterations and the long time to count FISH signals by fl uorescence microscopy [26, 27] .
We found signifi cant aberrant protein expression of tumor suppressor p16 in EAC tissue samples. In concert with our fi ndings, Langer et al. identifi ed a loss of p16 expression in 76% of immunohistochemically stained EAC samples [28] . Hardie et al. also found sizable loss of protein expression of p16 in 85% of the explored by IHC esophageal adenocarcinomas [29] . The expression of p16 in 23% of the specimens in our study supports the idea that p16 is not always implicated in the development of EAC and most likely other genetic disturbances could drive the uncontrolled cell proliferation and neoplastic progression. The pronounced lack of immunohistochemical expression of p16 protein in this study presumes that the cell cycle control is impaired in the examined EAC tissue samples.
Endoscopic brushing cytology specimens are normally used for FISH analysis of molecular changes in EAC, but FFPE tissue is also an attractive and proven option [30] . Moreover, use of FFPE tissue allows retrospective sample analysis [31] . Exploration of p16 (9p21) by FISH is successfully utilized for EAC detection [32] . We found prominent loss of p16 gene by means of FISH. In agreement with our fi ndings, although reporting higher rate of p16 locus loss, are data presented in other studies. Fahmy et al., using cytological specimens, found noticeable loss of the 9p21 signals in 9 (90%) of analyzed by FISH samples with EAC [33] . Similarly, Doak et al. reported a hemizygous deletion of p16 (9p21) in 7 (100%) patients with EAC in their study for determination of genetic alterations in EAC pathogenesis by FSIH [34] . In contrast to other studies, we did not observe a gain of chromosome 9 in samples with EAC. Fahmy et al. discovered a net gain of chromosome 9 in all EAC cases with p16 loss [33] . In the investigation performed by Brankley et al., 80% of the polysomic EAC cells showed hemizygous, homozygous, or relative loss of 9p21, whereas loss of 9p21 without associated chromosomal gain in EAC cells was not seen [35] . It is possible that molecular carcinogenesis of EАC is following distinct pathways in the cases when the loss of p16 occurs simultaneously with a gain of chromosome 9. Nevertheless, the abrogation of the normal p16 function could promote high cell proliferation rate in the esophageal tissue and enhance the development of EAC.
The estimated signifi cant correlation between the p16 protein expression and FISH signals in the current study could be due to the fact that p16 inactivation in EAC is often accomplished by allelic loss [14] . We must mention, however, that one of the analyzed specimens manifested positive p16 gene and negative p16 protein expression. Alternative mechanisms like p16 promoter methylation or p16 gene mutation could be the reasons for loss of p16 protein expression in this case. Methylation of p16 promoter is considered as common mechanism of p16 gene derailment during molecular pathogenesis of EAC, whereas p16 gene mutation is less probable [15, 36, 37, 38, 39] . It is plausible also that very small deletion of p16 could occur, which does not delete the entire LSI p16 probe target and consequently cannot be detected by FISH technique.
Limitation of this study is the relatively small number of analyzed patients. In patients with EAC, simultaneous exploration of gene and protein expression of other biomarkers (cyclin-D-cdk4/6 complex, retinoblastoma protein, E2F transcription factor and p53) interfering in the p16 signaling pathway could contribute to a better understanding of EAC.
CONCLUSION
Our data suggest that the absence of p16 protein expression and allelic loss of p16 gene are common molecular disturbances in EAC. Signifi cant association between protein and gene expression supposes that p16 (9p21) deletion account for appreciable part of the p16 protein loss in EAC. IHC and FISH are reliable methods for detection of p16 changes at protein and chromosomal level in EAC, but larger studies are needed to reveal the exact role of p16 in the carcinogenesis of EAC.
